These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31536379)

  • 1. Updated overview on von Willebrand disease: focus on the interest of genotyping.
    Itzhar-Baikian N; Boisseau P; Joly B; Veyradier A
    Expert Rev Hematol; 2019 Dec; 12(12):1023-1036. PubMed ID: 31536379
    [No Abstract]   [Full Text] [Related]  

  • 2. Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease.
    Franchini M; Mannucci PM
    Expert Rev Hematol; 2016 Sep; 9(9):825-30. PubMed ID: 27427955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the genetics and treatment of von Willebrand disease.
    Federici AB; Mannucci PM
    Curr Opin Pediatr; 2002 Feb; 14(1):23-33. PubMed ID: 11880730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
    Castaman G; Federici AB; Rodeghiero F; Mannucci PM
    Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand's disease: case report and review of literature.
    Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
    Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project.
    Pérez-Rodríguez A; Batlle J; Corrales I; Borràs N; Rodríguez-Trillo Á; Lourés E; Cid AR; Bonanad S; Cabrera N; Moret A; Parra R; Mingot-Castellano ME; Navarro N; Altisent C; Pérez-Montes R; Marcellini S; Moreto A; Herrero S; Soto I; Fernández Mosteirín N; Jiménez-Yuste V; Alonso N; de Andrés Jacob A; Fontanes E; Campos R; Paloma MJ; Bermejo N; Berrueco R; Mateo J; Arribalzaga K; Marco P; Palomo Á; Castro Quismondo N; Iñigo B; Nieto MDM; Vidal R; Martínez MP; Aguinaco R; Tenorio M; Ferreiro M; García-Frade J; Rodríguez-Huerta AM; Cuesta J; Rodríguez-González R; García-Candel F; Dobón M; Aguilar C; Batlle F; Vidal F; López-Fernández MF
    PLoS One; 2018; 13(6):e0197876. PubMed ID: 29924855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perioperative therapy of von Willebrand disease. Demonstration of pathophysiology, clinical problems and therapy options using two case reports].
    Kleinschmidt S; Fuchs-Buder T; Wilhelm W; Seyfert UT; Mörsdorf S
    Anaesthesist; 2002 Oct; 51(10):825-34. PubMed ID: 12395174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology of von Willebrand disease: therapeutic implications.
    Schneppenheim R
    Thromb Res; 2011; 128 Suppl 1():S3-7. PubMed ID: 22221847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of inherited von Willebrand disease: a clinical perspective.
    Federici AB
    Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
    Favaloro EJ
    Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagosis of von Willebrand disease.
    Ruan C
    Int J Hematol; 2002 Aug; 76 Suppl 2():145-8. PubMed ID: 12430915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype correlation in a cohort of Portuguese patients comprising the entire spectrum of VWD types: impact of NGS.
    Fidalgo T; Salvado R; Corrales I; Pinto SC; Borràs N; Oliveira A; Martinho P; Ferreira G; Almeida H; Oliveira C; Marques D; Gonçalves E; Diniz M; Antunes M; Tavares A; Caetano G; Kjöllerström P; Maia R; Sevivas TS; Vidal F; Ribeiro L
    Thromb Haemost; 2016 Jul; 116(1):17-31. PubMed ID: 26988807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, diagnosis, and management of von Willebrand disease in India.
    Ghosh K; Shetty S
    Semin Thromb Hemost; 2011 Jul; 37(5):595-601. PubMed ID: 22102205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture.
    Veyradier A; Boisseau P; Fressinaud E; Caron C; Ternisien C; Giraud M; Zawadzki C; Trossaert M; Itzhar-Baïkian N; Dreyfus M; d'Oiron R; Borel-Derlon A; Susen S; Bezieau S; Denis CV; Goudemand J;
    Medicine (Baltimore); 2016 Mar; 95(11):e3038. PubMed ID: 26986123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and management of von Willebrand disease].
    Higasa S; Tokugawa T; Sawada A
    Rinsho Ketsueki; 2018; 59(10):2222-2232. PubMed ID: 30305529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of von Willebrand disease in Australia.
    Favaloro EJ; Bonar R; Favaloro J; Koutts J
    Semin Thromb Hemost; 2011 Jul; 37(5):542-54. PubMed ID: 22102198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD).
    Budde U; Schneppenheim R; Eikenboom J; Goodeve A; Will K; Drewke E; Castaman G; Rodeghiero F; Federici AB; Batlle J; Pérez A; Meyer D; Mazurier C; Goudemand J; Ingerslev J; Habart D; Vorlova Z; Holmberg L; Lethagen S; Pasi J; Hill F; Peake I
    J Thromb Haemost; 2008 May; 6(5):762-71. PubMed ID: 18315556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of inherited von Willebrand disease in 2007.
    Federici AB; Mannucci PM
    Ann Med; 2007; 39(5):346-58. PubMed ID: 17701477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.